Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis
- 1 February 1992
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 23 (1-2), 43-49
- https://doi.org/10.1007/bf01831474
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Genetic evolution of breast cancer: II. relationship with estrogen and progesterone receptor expressionBreast Cancer Research and Treatment, 1992
- Breast cancer genetic evolution: I. Data from cytogenetics and DNA contentBreast Cancer Research and Treatment, 1991
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Cell kinetics as a prognostic indicator in node-negative breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancerInternational Journal of Cancer, 1989
- Relevance of DNA ploidy as a measure of genetic deviation: A comparison of flow cytometry and cytogenetics in 25 cases of human breast cancerCytometry, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapyBreast Cancer Research and Treatment, 1983
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983